News | March 12, 2024
AstraZeneca Pharma India, Mankind Pharma ink pact to distribute asthma medicine
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
Pfizer to discuss regulatory submission with FDA, potentially leading to eighth indication for ADCETRIS
The product combines proven efficacy of Doxylamine succinate 20 mg and Pyridoxine hydrochloride 20 mg in an Extended Release formulation
The validations confirm the completion of the applications and commence the scientific review process
Investigational cell therapy bemdaneprocel continues to be well tolerated with no major safety issues in all 12 participants in low and high dose cohorts through 18 months
The Convocation ceremony was organized for students skilled and certified in Ayush
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
Subscribe To Our Newsletter & Stay Updated
